To explore how many signaling transduction pathways might participate in FLJ10540-mediated cell migration and invasion in lung cancer cells, we first investigated three well-defined signaling pathways, namely the PI3K/AKT, p38, and MAPK pathways, using pharmacological inhibitors. The gene discussed is PIK3CA; the disease is lung carcinoma.